M6620 (VX-970) in Selected Solid Tumors
This research study is studying a drug called M6620 as a possible treatment for advanced solid tumor.
A Phase II Study of M6620 (VX-970) in Selected Solid Tumors
- ClinicalTrials.gov Identifier: NCT03718091
- Protocol Number: 18-274
- Principal Investigator: Andrea Bullock
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required